Last edition
News about "pulmonary hypertension"
Gossamer Bio Submits First NDA for Seralutinib in PAH
Gossamer Bio has filed an NDA for seralutinib, supported by Phase 3 PROSERA and Phase 2 TORREY study data.
Pulmonary Hypertension | 25/09/2026 | By News Bureau
Johns Hopkins Researchers Identify Human Resistin as Key Driver of Inflammatory Pathway
Researchers found that blocking human resistin with a targeted antibody reduced activation of the NLRP3 inflammatory pathway, pointing to a potential target for future therapies.
Pulmonary Hypertension | 07/09/2026 | By News Bureau | 112
Merck Showcases New Cardio-Pulmonary Data at ACC.26
Merck presented late-breaking data from phase-III and phase-II trials at ACC.26, highlighting advances in its cardio-pulmonary pipeline, including an investigational oral PCSK9 inhibitor and therapies for pulmonary hypertension.
Pulmonary Hypertension | 17/03/2026 | By News Bureau | 187
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy